Darenzepine

CAS No. 84629-61-8

Darenzepine( —— )

Catalog No. M32876 CAS No. 84629-61-8

Darenzepine is a muscarinic receptor inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 344 Get Quote
5MG 427 Get Quote
10MG 599 Get Quote
25MG 861 Get Quote
50MG 1150 Get Quote
100MG 1521 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Darenzepine
  • Note
    Research use only, not for human use.
  • Brief Description
    Darenzepine is a muscarinic receptor inhibitor.
  • Description
    Darenzepine is a muscarinic receptor inhibitor extracted from patent US 20170095465 A1.
  • In Vitro
    Darenzepine is a muscarinic receptor inhibitor which is useful for the treatment of CNS disorders.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    AChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    84629-61-8
  • Formula Weight
    347.41
  • Molecular Formula
    C21H21N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(\C(=O)N1CCN(C)CC1)=C/2\C=3C(C(=O)NC=4C2=CC=CC4)=CC=CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Eric Elenko, et al. Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation. US 20170095465 A1.
molnova catalog
related products
  • Lobelanidine

    Lobelanidine (8,10-Diphenyllobelidiol), which can be extracted from the above-ground parts of Lobelia chinensis Lour and Lobelia tupa, is an analogue of lobeline and shows a moderate affinity for nAChR.

  • VU0152099

    VU0152099 is a potent and selective M4 mAChR allosteric potentiator(EC50 = 380 ± 93 nM).

  • Cynandione A

    Cynandione A, an acetophenone derived from Cynanchum wilfordii, has anti-inflammatory activity and significantly reduces pro-inflammatory cytokine overexpression via macrophage α7 nAChR activation and subsequent IL-10 expression.